Free Trial

Tonix Pharmaceuticals (TNXP) Earnings Date, Estimates & Call Transcripts

Tonix Pharmaceuticals logo
$0.24 +0.00 (+0.21%)
As of 01/17/2025 04:00 PM Eastern

Tonix Pharmaceuticals Latest Earnings Summary

Upcoming
Earnings Date
Apr. 7Estimated
Actual EPS
(Nov. 12)
-$0.23 Beat By $1.80
Consensus EPS
(Nov. 12)
-$2.03

Tonix Pharmaceuticals issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.23, which beat analysts' consensus estimates of -$2.03 by $1.80. Quarterly revenue was reported to be $2.82 million, above the consensus estimate of $2.63 million. With a trailing EPS of -$52.74, Tonix Pharmaceuticals' earnings are expected to grow next year, from ($17.63) to ($5.41) per share.

TNXP Upcoming Earnings

Tonix Pharmaceuticals' next earnings date is estimated for Monday, April 7, 2025, based off prior year's reporting schedules.

Get Tonix Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tonix Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TNXP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TNXP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tonix Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($17.63) EPS
Next Year EPS Consensus Estimate: ($5.41) EPS

Tonix Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/7/2025
(Estimated)
-------
11/12/2024--$2.03-$0.23+$1.80-$0.23$2.63M$2.82M
8/16/2024--$9.91-$19.28 -$9.37-$19.28$3.50M$2.21M
5/13/2024Q1 2024-$16.64-$5.76+$10.88-$0.18$4.00M$2.48M
4/1/2024Q4 2023--$27.52 -$27.52-$0.86$3.95M$3.78M
11/9/2023Q3 2023-$47.68-$58.56 -$10.88-$1.83$5.80M$3.99M
8/10/2023Q2 2023-$88.96-$85.76+$3.20-$2.68--
5/8/2023Q1 2023-$80.00-$104.00 -$24.00-$3.25--
3/13/2023Q4 2022-$172.00-$112.00+$60.00-$0.56--

Tonix Pharmaceuticals Earnings - Frequently Asked Questions

Tonix Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based off last year's report dates. Learn more on TNXP's earnings history.

In the previous quarter, Tonix Pharmaceuticals (NASDAQ:TNXP) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.03) by $1.80. Learn more on analysts' earnings estimate vs. TNXP's actual earnings.

Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded annual revenue of $7.77 million.

Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded net income of -$116.66 million. TNXP has generated -$52.74 earnings per share over the last four quarters.

Tonix Pharmaceuticals's earnings are expected to grow from ($17.63) per share to ($5.41) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TNXP) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners